PHARMDEKO Stock Overview
Pharma Deko Plc engages in manufacturing, packaging, and marketing pharmaceutical and consumer products in Nigeria.
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
Pharma-Deko Plc Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₦1.83 |
| 52 Week High | ₦2.37 |
| 52 Week Low | ₦1.71 |
| Beta | 0.0027 |
| 1 Month Change | 0% |
| 3 Month Change | 0% |
| 1 Year Change | -3.17% |
| 3 Year Change | 36.57% |
| 5 Year Change | 22.00% |
| Change since IPO | -37.11% |
Recent News & Updates
Recent updates
Shareholder Returns
| PHARMDEKO | NG Beverage | NG Market | |
|---|---|---|---|
| 7D | 0% | 1.5% | -0.5% |
| 1Y | -3.2% | -19.0% | 118.4% |
Return vs Industry: PHARMDEKO exceeded the NG Beverage industry which returned -19% over the past year.
Return vs Market: PHARMDEKO underperformed the NG Market which returned 118.4% over the past year.
Price Volatility
| PHARMDEKO volatility | |
|---|---|
| PHARMDEKO Average Weekly Movement | 0% |
| Beverage Industry Average Movement | 6.7% |
| Market Average Movement | 8.0% |
| 10% most volatile stocks in NG Market | 11.8% |
| 10% least volatile stocks in NG Market | 3.2% |
Stable Share Price: PHARMDEKO has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine PHARMDEKO's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1962 | n/a | Isola Olukayode | www.pharmadekoplc.com |
Pharma Deko Plc engages in manufacturing, packaging, and marketing pharmaceutical and consumer products in Nigeria. It operates through three segments: Pharma, Consumer, and Contract. The company offers pharmaceutical products, such as Vitacee syrups and drops, Pharmadec syrups and drops, Brett mouthwash, Hexedene oral care medication, Parkalin range of cough syrup, Parkaling Pediatrics, Revitone Blood Tonic, Salins Liniment, Antasil tablets, Omepraz capsules, and Parkaprim tablets and suspension; and Sparxin, Pidiclox dry powder and capsules, and Amycin dry powder and capsules, as well as paracetamol under the Phardol Drops brand.
Pharma-Deko Plc Fundamentals Summary
| PHARMDEKO fundamental statistics | |
|---|---|
| Market cap | ₦396.98m |
| Earnings (TTM) | -₦141.61m |
| Revenue (TTM) | ₦469.58m |
0.8x
P/S Ratio-2.8x
P/E RatioIs PHARMDEKO overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| PHARMDEKO income statement (TTM) | |
|---|---|
| Revenue | ₦469.58m |
| Cost of Revenue | ₦435.21m |
| Gross Profit | ₦34.37m |
| Other Expenses | ₦175.98m |
| Earnings | -₦141.61m |
Last Reported Earnings
Dec 31, 2022
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.65 |
| Gross Margin | 7.32% |
| Net Profit Margin | -30.16% |
| Debt/Equity Ratio | 2.7% |
How did PHARMDEKO perform over the long term?
See historical performance and comparison